Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency.
about
Use of fibrates in the metabolic syndrome: A reviewPharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat UtilizationEffects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.Recombinant AAV Vectors for Enhanced Expression of Authentic IgG.Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVIIPromise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodiesGene therapy and peripheral nerve repair: a perspective.Progress toward improved therapies for inborn errors of metabolism.Viruses, Artificial Viruses and Virus-Based Structures for Biomedical Applications.The potential of toxin-based drug delivery systems for enhanced nucleic acid therapeutic delivery.Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.Lomitapide for the treatment of hypertriglyceridemia.Systematic Comparison and Validation of Quantitative Real-Time PCR Methods for the Quantitation of Adeno-Associated Viral Products.Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.A Scalable and Accurate Method for Quantifying Vector Genomes of Recombinant Adeno-Associated Viruses in Crude Lysate.OneBac 2.0: Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA.Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.Homozygous LPL p.Gly188Glu Mutation in a Mexican Girl With Lipoprotein Lipase Deficiency.Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control.Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.Fibrates in the management of atherogenic dyslipidemia.
P2860
Q26765234-021AEAE3-283C-47D9-958E-F795E1879C1CQ28550545-A511EE70-0A66-43E8-AC70-9696BF813C6CQ31096862-A63BDC13-8271-4322-B1B6-B8253E703831Q36058890-283B678E-62F8-4517-B53C-724608F012F1Q36226969-C46DC700-A7CB-44C7-9CBD-EE1441D8859CQ36547796-368C9275-84F7-41B9-AE90-E8189D863730Q37621530-82E9C690-2A13-494D-AD95-280D0D523F54Q38559511-986B269A-A098-44BE-84F7-FD883881053AQ38601073-4BEEA5A3-AC30-4F8F-BEBC-5816D6C6B986Q38818912-AB14914D-AC0D-43CC-ADB4-29735A05755EQ38934039-6B311ADD-2174-47D7-A596-F026B9851773Q38988355-085DD0E2-7688-4BB0-8680-58000B23FD79Q38992251-EDA67E01-694E-4C9A-A19C-B6D878E5279FQ39009624-7C2318B5-D61B-4B0E-974D-69CF456C023BQ39409371-1072B27D-B8A2-43B3-AC62-830F6FEB8558Q40207901-25922D51-99AF-41F4-A943-CC28436FB409Q40357060-C8080762-4C0D-429A-99A0-03B1E142ABFCQ40973802-F66C71F1-A9B6-431D-8666-7549B3B1D971Q42357243-C03BD057-F927-4679-B7C6-0299C7380698Q47110966-AEA9D5CE-79E4-4410-96DC-8F6392D4BDB1Q47547452-8DDEAD5A-9CB3-4D1C-9A74-BF5D0E6E0356Q48303077-8326AF9B-88E4-4FC7-8A0B-EAB1E4B614F9Q49571281-67FECC49-C45F-4E9F-8395-F22ED64E6400
P2860
Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Alipogene tiparvovec: a review ...... lipoprotein lipase deficiency.
@en
type
label
Alipogene tiparvovec: a review ...... lipoprotein lipase deficiency.
@en
prefLabel
Alipogene tiparvovec: a review ...... lipoprotein lipase deficiency.
@en
P2860
P921
P1433
P1476
Alipogene tiparvovec: a review ...... lipoprotein lipase deficiency.
@en
P2860
P2888
P304
P356
10.1007/S40265-014-0339-9
P577
2015-02-01T00:00:00Z
P6179
1018653556